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 
 Abstract— Using sleep laboratory polysomnography (PSG) is 
restricted for the diagnosis of only the most severe sleep disorders 
due to its low availability and high cost. Home PSG is more 
affordable, but applying conventional electroencephalography 
(EEG) electrodes increases its overall complexity and lowers the 
availability. Simple, self-administered single-channel EEG 
monitors on the other hand suffer from poor reliability. In this 
study, we aimed to quantify the reliability of self-administrated 
home PSG recordings conducted with a newly designed 
ambulatory electrode set (AES) that enables multi-channel EEG, 
electrooculography, electromyography and electrocardiography 
recordings. We assessed the sleep study success rate and technical 
quality of the recordings performed in subjects with possible 
sleep bruxism (SB). Thirty-two females and five males aged 
39.6±11.6 years (mean±SD) with self-reported SB were recruited 
in the study. Self-administrated home PSG recordings with two 
AES designs were conducted (n=19 and 21). The technical quality 
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of the recordings was graded based on the proportion of 
interpretable data. Technical failure rate for AES (both designs) 
was 5% and SB was scorable for 96.9% of all recorded data. 
Only one recording failed due to mistakes in self-applying the 
AES. We found that the proportion of good quality self-
administrated EEG recordings is significantly higher when 
multiple channels are used compared to using a single channel. 
Sleep study success rates and proportion of recordings with high 
quality interpretable data from EEG channels of AES were 
comparable to that of conventional home PSG. Self-applicable 
AES has potential to become a reliable tool for widely available 
home PSG. 
 
Index Terms— Biomedical electrodes, electroencephalography, 
electromyography, printed circuits, thick film sensors.  
 
I. INTRODUCTION 
leep disorders cause significant harm on the health and 
well-being for millions of people worldwide and are costly 
for the healthcare system [1]–[4]. Currently, sleep 
laboratory polysomnography (PSG) is the gold standard 
method for diagnosing various sleep disorders, such as 
obstructive sleep apnea and narcolepsy [5]. However, it is 
considered to be cumbersome and expensive. In addition, 
sleep laboratory facilities are not easily available everywhere, 
especially in rural areas. Due to high costs and limited 
availability, use of sleep laboratory PSG has usually been 
prioritized mainly for the diagnosis of the clinically most 
severe sleep disorders. 
 PSG at home setting with its lower costs [6] may be more 
feasible compared to sleep laboratory PSG. However, the full 
diagnostic potential of home PSG is limited by the 
conventional electroencephalography (EEG) electrodes that 
need to be applied by a technician. The complexity of 
electrode appliance limits the availability of full home PSG 
only to be provided by facilities that have personnel with skills 
in EEG electrode appliance. Recently, devices with simple 
single channel EEG electrodes have been introduced with the 
possibility of patient self-appliance [7]–[9]. However, in 
recordings with a single EEG channel there is a high risk of 
total failure of the recording due to detachment, misplacement 
or failure of an EEG electrode [7], [9]. 
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 We have recently introduced a silver ink screen-printed and 
hydrogel-coated ambulatory electrode set [10] (AES) for 
emergency assessment of EEG [11]. AES is easy and quick to 
apply and in comparison to sleep laboratory PSG it has been 
shown to be suitable for sleep staging and determination of 
total sleep time [12] as well as detecting sleep bruxism events 
[13]. To our best knowledge, there are currently no other 
multi-channel EEG, EOG and EMG electrode sets for sleep 
monitoring that could be applied by patients themselves. AES 
has a large range of applications in the diagnostics of sleep 
disorders. However, originally it has not been designed to be 
used at home or tested in a home setting. We hypothesize that 
the AES could be developed to be easily self-applicable by 
patients, enabling more available, reliable and good quality 
home PSG recordings. We also hypothesize that using multi-
channel EEG, EOG and EMG in self-applied home PSG 
enhances the success rates of the recordings compared to 
single-channel recordings. In this study, we specifically tested 
the success rate and the technical quality of home PSG 
recordings made with AES in subjects with possible sleep 
bruxism (SB). 
 SB is a sleep-related movement disorder that is currently 
underdiagnosed due to the limited availability of sleep 
laboratory PSG required to make a definite diagnosis [14]. 
Self-reported SB is considered sufficient only for a 'possible' 
diagnosis [14]. It needs to be confirmed with a clinical 
examination ('probable' diagnosis) and with PSG ('definite' 
diagnosis) [14]. PSG diagnosis of SB is based on the rhythmic 
masticatory muscle activity (RMMA) index, determined as the 
number of RMMA events per total sleep time [15]. The 
current commonly used RMMA index cut-off value for 
positive SB diagnosis is ≥2, with diagnosis additionally 
requiring positive tooth-grinding history or confirmed 
grinding in audio recording [15]. 
Accurate determination of RMMA index requires recording 
of a combination of different biosignals. Masseter (and/or 
temporal) muscle electromyography (mass-EMG) is needed 
for the detection of RMMA events. RMMA events consist of 
EMG bursts that are scored on masseter or temporalis EMG 
channels when the EMG amplitude rises to a level of at least 
10 % of maximum voluntary clenching activity [15] or twice 
the baseline amplitude [16] for a minimum duration of 0.25 s. 
Recognition of the subtypes of RMMA (phasic, tonic or 
mixed) is important, since they are associated with different 
clinical signs and symptoms of SB [17]. A phasic RMMA 
event consists of at least three bursts lasting 0.25 s to 2 s with 
maximum of 2 s in between [15]. A tonic RMMA event 
corresponds to a burst with a duration longer than 2 s and a 
mixed RMMA event includes both tonic and phasic bursts 
[15]. Audio-video recordings are needed for distinguishing 
RMMA events from other orofacial or muscular activities (e.g. 
yawning, swallowing or changing position) to prevent possible 
overestimation of the number of RMMA events  [18],[19] and 
to confirm SB diagnosis with the presence of teeth-grinding 
sounds [15]. In addition, EEG, electrooculography (EOG) and 
submental EMG (sub-EMG) recordings are needed for sleep 
staging, determination of total sleep time and distinguishing 
SB from bruxism during wakefulness [15]. Portable EMG 
devices have been developed for simple diagnostics of SB [20] 
–[26], but their diagnostic accuracy compared to sleep 
laboratory PSG is questionable due to the lack of EEG based 
sleep staging and ability to distinguish between SB and other 
facial or muscular activities. 
Currently, practitioners of sleep medicine make the analysis 
for the diagnosis subjectively by identifying sleep stages and 
events based on the recorded signals manually. However, if 
available and reliable, automatic sleep stage and event 
detection would be less time-consuming. Micro-arousals 
precede most RMMA events [27], which makes an increase in 
EEG and electrocardiography (ECG) activity potential 
markers for more accurate automatic RMMA event 
recognition. Castroflorio et al. have shown that automatic 
RMMA event recognition based on detecting increased heart 
rate before RMMA events when recorded with portable device 
leads to high RMMA index agreement with subjectively 
analyzed portable PSG [25]. High quality recording 
techniques are the best way to prevent erroneous results in 
automatic analyses [28]. Thus, a detailed analysis of the 
quality of the signals and the sources for avoidable technical 
artifacts is a prerequisite for the estimation of the potential of 
using automatic analysis methods. 
 The aim of this study was to quantify the reliability of the 
self-applied home PSG recordings conducted with a newly 
designed multi-channel AES in subjects with self-reported SB. 
The reliability was assessed by the means of success rate and 
technical quality of the recordings and signals. Detailed 
reasons for signal losses were also assessed as well as 
electrical impedances of the electrodes and subjective quality 
of applying the electrodes. 
II. METHODS 
A. Subjects 
Recordings for the assessment of the reliability of AES in 
home PSG for SB diagnostics were conducted in two stages. 
Eighteen female and one male voluntary subjects aged 40.9 ± 
11.9 years (mean ± SD) were recruited for the recordings 
conducted in stage 1. In stage 2, sixteen females and five 
males aged 38.4 ± 11.7 years were recruited, of which two 
females and one male participated also in stage 1. All subjects 
in stage 1 and eleven subjects in stage 2 were recruited from 
volunteers that responded to an open call for test subjects 
posted in intrawebs of Kuopio University Hospital (KUH, 
Kuopio, Finland) and University of Eastern Finland (UEF, 
Kuopio, Finland). Ten subjects in stage 2 were recruited by 
author J.A. from volunteered patients in a dental clinic of the 
Unit of Specialized Oral Care in the Metropolitan Area and 
Kirkkonummi (Helsinki, Finland). 
Inclusion criteria for all subjects was self-reported SB that 
occurred at least one night per week. Informed consent was 
obtained from all individual participants included in the study. 
The study protocol was reviewed by the Research Ethics 
Committee of the Hospital District of Northern Savo, Kuopio, 
Finland (favorable opinion: 34/2013) and a permission was 
obtained from the National Supervisory Authority for Welfare 
and Health (Valvira, 220/2013). 
B. Electrode set and its development stages 
For stage 1 of the study, a new design of the ambulatory 
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electrode set (AES-1, Fig. 1a), enabling easier self-application 
was developed from the original emergency EEG electrode 
set. The materials and the layer structure of the new AES-1 are 
similar to the original set and described in detail elsewhere 
[10]. All materials in contact with the skin are approved for 
medical use. 
AES-1 consists of two parts (Fig. 1a). The larger part had 
four EEG electrodes (Af8, Fp2, Fp1, Af7), one ground 
electrode (Gnd) and one extra reference electrode (Ref) 
positioned on the forehead, two electrodes for EOG positioned 
in F8 and F7, four masseter EMG (mass-EMG) electrodes 
(MassL, MassR, two bilaterally) and two mastoidal reference 
electrodes (T10, T9). The smaller part of AES-1 consisted of 
three submental (sub-EMG) electrodes (S1, S2, SF). 
 Based on the technical quality of the data and subject 
questionnaire results of stage 1 recordings, an improved 
electrode set (AES-2) was developed and tested in stage 2 
(Fig. 1b). EEG electrodes Af8 and Af7 were repositioned 5 
mm and Fp2 and Fp1 2 mm closer to the vertical centerline of 
the face to prevent applying the electrodes on top of the hair. 
Ref electrode was removed as unused and the ground 
electrode Gnd was made larger for improved electrical contact 
with skin. Laser-cut outline of the polyester film was changed 
to cover less skin and thus reduce sweating. The long 
polyester strips extending from the facial area to chest area 
were found to be uncomfortable and were replaced with longer 
cables which were attached to sockets near the mass-EMG 
electrodes. ECG electrode strip was introduced in AES-2, with 
ECG2 electrode to be positioned on top of heart and ECG1 
electrode in 45° angle to horizontal line and to be placed 
approximately on the middle vertical line of the chest. 
C. Data acquisition 
All home PSG recordings were conducted by using Nox A1 
portable polysomnography system (Nox Medical, Reykjavík, 
Iceland) with respiratory inductance plethysmography (RIP) 
chest band that also holds the recording device on the chest. 
Nox A1 was supplemented in stage 1 with an ECG monitor 
eMotion Faros 180° (Mega Electronics Ltd, Kuopio, Finland) 
with bipolar derivation, one electrode positioned on top of 
heart and the other one horizontally on the opposite side of the 
chest. 
AES and rest of the equipment needed for home PSG 
recordings were given and introduced to subjects the same day 
the PSG recording was to take place. A skilled technician (in 
stages 1 and 2, studies conducted from the Department of 
Clinical Neurophysiology of KUH) or a dentist having had a 
two-hour introduction to the used PSG equipment (in stage 2, 
studies conducted from the dental clinic) instructed subjects 
how to apply the AES and other PSG equipment by 
themselves before going to sleep. Written instructions with 
detailed illustrations were also given to subjects to take home 
for referring to when applying the equipment. Subjects were 
asked to fill in a set of questionnaires, which included 
questions concerning the time of going to sleep, falling asleep 
and waking up,  ease of applying the AES and other PSG 
equipment on scale from 1 = easy to 10 = difficult, as well as 
problems encountered during the night with the equipment. 
The PSG recording device was programmed by a technician 
or the dentist to automatically turn on and record for a pre-set 
duration of time, depending on subject’s approximation for the 
time of going to sleep and waking up. Before going to sleep, 
subjects were told to prepare the skin by wiping the electrode 
attachment sites with a disposable disinfectant wipe. After the 
recordings, subjects returned all recording devices to the 
facility they were given from. 
The recording montage in stage 1 consisted of four EEG 
derivations (Fp1-T10, Fp2-T9, Af8-T9, Af7-T10), two EOG 
derivations (F8-T9, F7-T10), two sub-EMG derivations (S1-
SF and S2-SF) and two bipolar mass-EMG derivations from 
MassL and MassR electrodes. ECG was recorded with the 
separate bipolar ECG monitor in stage 1, which was 
temporally synchronized with the PSG recording device. PSG 
device had embedded activity, position and audio recordings 
as well as recording of respiratory movements with a RIP 
band. The PSG recording device measured the electrode 
impedances through the night. Recording montage in stage 2 
was similar, except for the separate ECG device that was 
replaced with ECG electrodes of AES-2 (ECG recorded with 
the Nox A1 recording device). 
D. Analysis 
Technical quality of scored recordings was graded by the 
primary author (T.M.) according to a modified version of the 
grading system introduced by Redline et al. [29], originally 
developed for unattended PSG conducted to diagnose sleep-
disordered breathing. In this system, all channels were given a 
quality grade based on duration of interpretable signal, which 
formed the basis for the overall grading of each study. The 
 
Fig. 1.  Ambulatory electrode sets. Photographs of the screen printed 
ambulatory electrode sets (AES) and other sensors and devices used in the 
recordings and diagrams of corresponding electrode positions used in (a) 
stage 1 of the study (AES-1) and in (b) stage 2 of the study (AES-2). 
Separate ECG monitor applied in stage 1 and ECG electrodes applied in 
stage 2 are not visible in the photographs. 
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applied grading system was modified by replacing the 
channels needed in diagnostics of sleep-disordered breathing 
with ones recorded to diagnose SB (Table I). The subjective 
dichotomization of signal quality as interpretable or non-
interpretable was made channel-wise by marking the non-
interpretable or artifact-ridden periods of the signal in the 
recordings. The channels were chosen as the ones needed in 
determining the RMMA index: detecting RMMA events and 
distinguishing them from other events (Fig. 2) or determining 
total sleep time. Reasons for signal losses or technical artifacts 
in all channels were analyzed from the recordings during the 
grading. Subjects’ accounts on encountered problems during 
the study were used as supplementary material in the analysis.  
Proportions of total scorable data to total recording time 
were also determined. Recorded data were considered scorable 
for SB at any time point, if it included the following: at least 
one interpretable EEG channel for the assessment of subject 
being in sleep or awake; one interpretable mass-EMG channel 
for the recognition of bruxism episodes; and audio recording 
for distinguishing SB from other orofacial or muscular 
activities. Total recording time was determined as the time 
between subject going to bed and subject waking up. The time 
of subject going to bed (starting point of analysis) was set at 
the earliest time point when the continuous movement activity 
in actigraph and other channels seized before falling asleep 
close to the subject’s reported time of going to sleep. The 
ending point of the analysis was set to the time point of 
subject waking up. The time points of falling asleep and 
waking up were determined based on sleep stage scoring of 
EEG. In stage 1, sleep stages were scored by an experienced 
KUH clinical neurophysiologist (S.W-P.). In stage 2, scoring 
was made by an expert technologist (Oivauni Oy, Kuopio, 
Finland), certified by European Sleep Research Society. All 
sleep scorings were carried out in 30 second epochs with 
Noxturnal software (Nox Medical, Reykjavík, Iceland) 
according to AASM guidelines [16]. The rule for scoring N1 
sleep in subjects who do not create alpha rhythm was used, 
because the recording montage did not include occipital 
electrodes that are necessary for the recognition of the alpha 
rhythm [16]. 
Electrical impedances of all working electrodes recorded by 
the PSG device were analyzed by taking a 60 second mean 
impedance value every hour from the time of going to sleep. 
The first impedance value was taken from the time point of 
subject going to bed and rest of the impedance data points 
every full hour after this. 
Subject questionnaire results concerning the ease of 
applying AES and other PSG equipment were statistically 
analyzed using SPSS software (version 21.0; SPSS, Chicago, 
IL, USA). Shapiro-Wilk test was used to evaluate whether the 
data sets follow normal distribution. Mann-Whitney U-test 
was used for the comparison of mean values of the ease of 
applying the AES and other PSG equipment.  Threshold for 
statistical significance was p = 0.05. 
III. RESULTS 
Out of the forty sleep studies conducted, the quality of 
thirty-six recordings (90 %) was graded “good” or better, and 
two recordings (5 %, one recording in both stages) were 
considered as failed (Table II). The failed recording in stage 1 
TABLE I 
TECHNICAL QUALITY GRADING SYSTEM OF THE RECORDINGS 
Quality Grade Requirements for the Grade 
Outstanding All channels good for ≥ 6 h 
Excellent At least 2xEEG, 1x EOG, sub-EMG, mass-EMG and 
audio, ECG good for ≥ 5 h 
Very Good At least 1xEEG, EOG, sub-EMG, mass-EMG and 
audio good for ≥ 5 h 
Good At least 1xEEG, mass-EMG and audio good for ≥ 5 h 
Fair At least 1xEEG, mass-EMG and audio good for ≤ 5 h 
but ≥ 4 h   
Poor EEG, mass-EMG and audio channels contain ≤ 4 h of 
interpretable data 
Unsatisfactory No usable data, less than 2 hours on all channels 
Recordings rated poor or unsatisfactory were considered as failed 
recordings. Modified from [29]. EEG = electroencephalography, EOG = 




Fig 2. Flow chart for detecting RMMA events and distinguishing RMMA events from other events with ambulatory electrode set and PSG recording equipment 
used in this study. The channels that are used in the decision making are in parenthesis inside the boxes. Subjective evaluation of detected RMMA events includes 
listening to the audio playback and scoring the sleep stages to distinguish the type of the event. Inside the dashed box on the left side of the figure is the suggested 
additional step to enhance the accuracy of the initial RMMA event detection, if the automatic RMMA detection methods would be implemented. 
 AB = awake bruxism, ECG = electrocardiography, EEG = electroencephalography, EOG = electrooculography, sub-EMG = submental electromyography, EMG 
= electromyography, PSG = polysomnography, RMMA = rhythmic masticatory muscle activity, SB = sleep bruxism. 
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TABLE II 
TECHNICAL QUALITY GRADES OF THE RECORDINGS 
Quality Grade  All Recordings Stage 1 Stage 2 
Outstanding 15 (37.5 %) 7 (37 %) 8 (38 %) 
Excellent 17 (42.5 %) 10 (53 %) 7 (33 %) 
    Bad contact in EEG working electrode, 7 (37 %) Bad contact in EEG working electrode, 2 (9.5 %) 
    EEG or EOG sweat artifact 2 (11 %) TRT less than six hours, 2 (9.5 %) 
    Bad contact in submental reference electrode, 1 (5.3 %) Bad contact in masseter-EMG electrode, 1 (4.8 %) 
      Recording ended prematurely, 1 (4.8 %) 
      EEG or EOG sweat artifact, 1 (4.8 %) 
Very Good 0 (0.0 %) 0 (0 %) 0 (0 %) 
Good 4 (10 %) 0 (0 %) 4 (19 %) 
     - Submental EMG electrodes’ cable detachment, 4 (19.0 %) 
Fair 2 (5 %) 1 (5 %) 1 (5 %) 
    Bad contact in EEG reference electrodes, 1 (5.3 %) Submental EMG electrodes’ cable detachment, 1 (4.8 %) 
Poor 1 (2.5 %) 1 (5 %) 0 (0.0 %) 
    Recording device malfunction, 1 (5.3 %)  - 
Unsatisfactory 1 (2.5 %) 0 (0.0 %) 1 (5 %) 
  - Electrode covers were not removed, 1 (4.8 %) 
Number and proportion of recordings with corresponding technical quality grades and reasons for grades lower than "outstanding" for recordings conducted 
in stage 1 and stage 2 of the study with the new designs of the ambulatory electrode sets. Recordings rated poor or unsatisfactory were considered as failed 
recordings.  
EEG = electroencephalography, EOG = electrooculography, EMG = electromyography, TRT = Total recording time. 
 was due to a partial loss of all recorded data, caused by a 
malfunction of the recording device. The failed recording in 
stage 2 was due to a mistake in electrode attachment as the 
subject did not remove electrode covers before going to bed. 
When full data losses caused by the recording device were 
excluded, SB could be scored for 96.9 % of all TRT. 
There were various reasons for data losses causing study 
quality being other than “outstanding” (Table II). However, in 
most of the cases these problems were restricted only to a 
small proportion of the electrodes at a time. At least one 
channel (any single channel) in all signal groups (EEG, EOG, 
sub-EMG, mass-EMG, ECG) had the highest quality grade 
“A” (more than 95 % of interpretable data) in 84 % or more of 
the recordings made in stage 1 (Table III). Similarly, in 
recordings made in stage 2 the proportion of recordings with 
the highest quality grade “A” in any channel within the signal 
group was almost at the same level (81 % or more) with the 
exception of sub-EMG signal group that had significantly 
more problems on both channels at the same time. In single 
channels, proportions of the recordings with quality grade “A” 
were generally lower compared to the situation where 
proportion of interpretable data is taken from any channel. 
A more detailed description of the reasons behind signal 
losses is presented in Table IV. In 37 % (stage 1) and 24 % 
(stage 2) of the recordings, at least one electrode had initial 
bad contact that caused signal loss that started from the 
beginning of the recording. Most of the initial signal quality 
problems were in EEG channels Af8-T9 and Af7-T10, 
especially in stage 1 recordings. According to subjects’ 
feedback, in some cases electrodes Af8 and Af7 had to be 
applied too close to hairline due to their fixed positions in the 
electrode set. Changing the positions of Af8 and Af7 
electrodes further away from the hairline led to smaller 
proportion of lost signal in these electrodes due to bad 
electrode contact in stage 2 (4.5 % and 4.1 %, respectively) 
compared to stage 1 (10.7 % and 28.9 %, respectively). In 
stage 2, the highest proportion of lost signal was in sub-EMG 
signals due to cable detachment. In addition, mistakenly set 
wrong recording times and increased sweat artifact were an 
issue in stage 2 recordings. Out of the 21 recordings in stage 2, 
temporally 76.3 % of all signal losses happened in ten 
recordings made in the dental clinic. 
TABLE III 






























Stage 1                
A: 100 % - 95 % 79 % 69 % 68 % 42 % 84 % 84 % 74 % 84 % 68 % 84 % 90 % 79 % 84 % 90 % 90 % 
B: 94 % - 75 % 11 % 26 % 11 % 21 % 11 % 11 % 21 % 11 % 16 % 11 % 10 % 11 % 16 % 10 % 10 % 
C: 74 % - 50 % 10 % 5 % 11 % 5 % 5 % 5 % 5 % 5 % 16 % 5 % - 5 % - - - 
D: <50 % - - 10 % 32 % - - - - - - - 5 % - - - 
Stage 2                
A: 100 % - 95 % 71 % 76 % 57 % 52 % 81 % 81 % 76 % 81 % 67 % 67 % 67 % 85 % 86 % 90 % 90 % 
B: 94 % - 75 % 10 % 14 % 29 % 24 % 9 % 9 % 10 % 9 % - - - 5 % - 5 % 5 % 
C: 74 % - 50 % 14 % 5 % 5 % 14 % 5 % 5 % 9 % 5 % 9 % 9 % 9 % 5 % - - - 
D: <50 % 5 % 9 % 9 % 10 % 5 % 5 % 5 % 5 % 24 % 24 % 24 % 5 % 14 % 5 % 5 % 
Signal quality of the recordings with the new designs of the ambulatory electrode set in stage 1 and stage 2 of the study. Signal quality is expressed channel-
wise as proportion of recordings with interpretable data lasting 100% - 95%, 94% - 75%, 74% - 50% and less than 50 % of the recorded signal. Full data losses 
caused by recording device malfunction or problems in setting up the recording device are excluded from this table. Audio was distortion free in all recordings. 
ECG = electrocardiography, EEG = electroencephalography, EOG = electrooculography, sub-EMG = submental EMG, mass-EMG = masseter EMG. 
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Electrical impedances of electrodes were below 75 kΩ in 
approximately 90 % of the measured data points in stage 1 
with AES-1, except of electrodes Af8 and Af7 (Table V).  
These two electrodes had impedance values higher than 300 
kΩ in 25 % and 42 % of data points, usually at device 
maximum value of 328 kΩ. Repositioning the electrodes in 
stage 2 lowered the electrical impedances. Generally, 
electrical contact of the electrodes on skin showed no 
significant decay during recordings in terms of electrical 
impedance and bad electrical contact was most often present 
from the beginning of the recording presumably as the result 
of inadequate preparation of skin or electrode misplacement. 
Recorded signals included clearly recognizable events of 
different subtypes of SB with concomitant teeth-grinding and 
arousal events (Fig. 2). There were no significant differences 
in the perceived ease of applying AES between stage 1 and   
stage 2 (Table VI). On the average, all of the parts of AES 
were considered easy to apply. 
IV. DISCUSSION 
The aim of this study was to 
quantify the reliability of the 
self-applied home PSG 
recordings conducted with a 
newly designed AES in subjects 
with self-reported SB. The 
failure rate of unattended home-
PSG with AES was 5 %. It is 
comparable or even lower to 
failure rates of unattended type 2 
home-PSG, in which electrodes 
are applied by a medical 
professional (4 – 8 % [30]–[33] 
and 20 % [34]). Self-applicability 
of AES seems to be reliable, 
since only one recording failed 
due to problems in applying the 
AES. However, relatively high 
number of recordings (37 % and 
24 % in stages 1 and 2 
respectively) had at least one 
electrode with initial bad contact 
causing signal losses from the 
beginning of the recording. This 
was caused mostly by the fact 
that the size of the electrode sets 
TABLE IV 







F8-T9 F7-T10 S1-SF S2-SF MassL MassR ECG 
Stage 1            
Total bad quality or lost signal 8.1 % 7.2 % 17.3 % 35.5 % 5.8 % 6.3 % 7.3 % 4.8 % 11.9 % 4.5 % 1.0 % 
Non-interpretable or missing signal 4.8 % 3.1 % 13.3 % 31.4 % 2.6 % 2.5 % 5.0 % 2.5 % 9.6 % 2.2 % 1.0 % 
  Bad contact in working electrode 2.2 % 0.6 % 10.7 % 28.9 % 0.0 % 0.0 % 4.4 % 1.9 % 3.1 % 1.6 % 1.0 % 
  Cable detachment - - - - - - - - 6.0 % - - 
  Bad contact in reference electrode 2.0 % 1.9 % 2.0 % 1.9 % 2.0 % 1.9 % - - - - - 
  Bad contact in ground electrode 0.6 % 0.6 % 0.6 % 0.6 % 0.6 % 0.6 % 0.6 % 0.6 % 0.6 % 0.6 % - 
Sweat artifact 1.0 % 1.8 % 1.7 % 1.8 % 0.9 % 1.5 % - - - - - 
Recording device malfunction 2.3 % 2.3 % 2.3 % 2.3 % 2.3 % 2.3 % 2.3 % 2.3 % 2.3 % 2.3 % - 
            
Stage 2            
Total bad quality or lost signal 15.4 % 18.4 % 20.6 % 23.0 % 15.1 % 17.3 % 26.3 % 25.4 % 13.8 % 18.3 % 12.5 % 
Non-interpretable or missing signal 3.8 % 6.2 % 8.2 % 9.2 % 3.7 % 5.1 % 18.2 % 17.3 % 5.7 % 10.2 % 4.4 % 
  Bad contact in working electrode 0.1 % 1.1 % 4.5 % 4.1 % - - 1.0 % 0.1 % 2.3 % 6.8 % 0.1 % 
  Cable detachment - - - - - - 13.8 % 13.8 % - - 1.0 % 
  Bad contact in reference electrode 0.3 % 1.7 % 0.3 % 1.7 % 0.3 % 1.7 % - - - - - 
  Bad contact in ground electrode 0.1 % 0.1 % 0.1 % 0.1 % 0.1 % 0.1 % 0.1 % 0.1 % 0.1 % 0.1 % - 
  Electrode covers not removed 3.3 % 3.3 % 3.3 % 3.3 % 3.3 % 3.3 % 3.3 % 3.3 % 3.3 % 3.3 % 3.3 % 
Sweat artifact 3.5 % 4.1 % 4.3 % 5.7 % 3.3 % 4.1 % - - - - - 
Wrong recording time 8.1 % 8.1 % 8.1 % 8.1 % 8.1 % 8.1 % 8.1 % 8.1 % 8.1 % 8.1 % 8.1 % 
Reasons for signal losses in the recordings with new designs of the ambulatory electrode set in stage 1 and stage 2 of the study. Data are expressed as ratio of 
total duration of lost signals to sum of total recording times in all recordings. 
 
TABLE V 
ELECTRICAL IMPEDANCES OF THE WORKING ELECTRODES OF AMBULATORY ELECTRODE SET. 
Z (kΩ) Fp2 Fp1 Af8 Af7 F8 F7 S1 S2 SF MassL MassR 
Stage 1            
0 - 10 29 % 61 % 8 % 14 % 24 % 68 % 29 % 48 % 33 % 0 % 0 % 
10 - 20 30 % 16 % 9 % 20 % 32 % 12 % 66 % 46 % 58 % 18 % 14 % 
20 - 30 12 % 9 % 15 % 8 % 19 % 9 % 3 % 2 % 5 % 43 % 61 % 
30 - 40 10 % 2 % 20 % 5 % 10 % 0 % 0 % 3 % 0 % 14 % 12 % 
40 - 50 3 % 1 % 5 % 0 % 3 % 0 % 0 % 1 % 0 % 14 % 11 % 
50 - 75 2 % 1 % 10 % 3 % 2 % 1 % 0 % 0 % 0 % 4 % 1 % 
75 - 100 1 % 2 % 2 % 1 % 1 % 1 % 0 % 0 % 0 % 0 % 0 % 
100 - 200 2 % 0 % 2 % 5 % 1 % 1 % 0 % 0 % 3 % 0 % 0 % 
200 - 300 3 % 1 % 3 % 1 % 2 % 3 % 0 % 0 % 0 % 0 % 0 % 
> 300 7 % 7 % 25 % 42 % 6 % 5 % 3 % 1 % 0 % 7 % 0 % 
            
Stage 2            
0 - 10 35 % 35 % 16 % 13 % 37 % 42 % 39 % 37 % 33 % 0 % 4 % 
10 - 20 32 % 36 % 31 % 30 % 41 % 35 % 42 % 47 % 47 % 19 % 13 % 
20 - 30 13 % 17 % 19 % 11 % 10 % 11 % 2 % 2 % 2 % 42 % 42 % 
30 - 40 7 % 2 % 5 % 12 % 3 % 2 % 9 % 4 % 6 % 27 % 31 % 
40 - 50 1 % 2 % 2 % 7 % 1 % 3 % 0 % 0 % 0 % 5 % 0 % 
50 - 75 4 % 1 % 12 % 9 % 2 % 1 % 2 % 0 % 0 % 2 % 1 % 
75 - 100 1 % 2 % 4 % 6 % 1 % 1 % 0 % 0 % 0 % 1 % 1 % 
100 - 200 4 % 2 % 4 % 6 % 4 % 4 % 0 % 0 % 6 % 4 % 6 % 
200 - 300 0 % 0 % 0 % 0 % 0 % 0 % 1 % 1 % 1 % 0 % 2 % 
> 300 2 % 2 % 6 % 7 % 2 % 2 % 6 % 9 % 4 % 0 % 0 % 
Electrical impedances (Z) of electroencephalography, electrooculography and electromyography electrodes in the 
recordings with the new designs of the ambulatory electrode set in stage 1 and stage 2 of the study. Data are 
expressed as percentage of data points within a corresponding range of impedance values. Data points have been 




was fixed and it had to be applied too close to hairline in 
subjects with narrower faces. In the future, the scalability of 
the electrode set size should be utilized in the production 
process to make different sized electrode sets that fit different 
sized faces better. Another solution would be to use 
stretchable materials instead of nonstretchable polyester films 
as the base for the electrode sets [35]. 
Signal losses were generally restricted to maximum of a few 
channels at the time when total signal losses caused by 
recording device malfunction or erroneous set up were 
excluded. In a recent unattended home PSG study, Bruyneel et 
al. [33] had more than 95 % of interpretable data (quality 
grade “A”) in both EEG channels in 84 % of the recordings 
when type 2 PSG equipment for obstructive sleep apnea 
diagnostics were fitted at home by a technician. In this study 
this was 84 % and 81 % for any EEG channel and 42-79 % 
and 52-76 % for single EEG channels (in stages 1 and 2, 
respectively). Bruyneel et al. [33] suggested that the risk for 
EEG data loss is not decreased with higher number of EEG 
channels (four channels instead of two). In contrast to the 
study of Bruyneel et al., we found that a high number of EEG 
channels was beneficial for the success of patient-applied EEG 
in unattended home PSG.  
The AES-2 design in stage 2 imposed a problem in the cable 
of sub-EMG electrodes that easily became detached, causing 
significant data losses in total of five recordings graded 
“good” or “fair” (Table II). This problem could be solved by 
introducing wireless data transfer or more securely connected 
cables between AES and recording device in future 
development stages. Wireless data transfer would be 
preferable as it would also reduce noise and movement 
artifacts, make the AES more comfortable to use, and simplify 
the self-applicability. 
A significant amount of sweat artifact [36] was present in 
EEG and EOG channels in recordings made with both AES 
designs. In order to alleviate it AES-2 was designed to cover 
less skin than AES-1 for improved heat transfer from skin. 
However, the artifact still persisted and its presence actually 
increased in recordings made with AES-2. Sweating as the 
source of the artifact cannot be fully removed, since sweating 
also depends on the temperature of the sleeping environment 
and sweating tendency of the subject. Sweating artifact could 
be removed with high-pass filtering but this would affect the 
recognition of slow delta waves in N3 sleep stages negatively. 
Some of the reasons for signals being uninterpretable were 
unexpected. Errors in setting up the recording device led to 8.1 
% of total recordings time being lost in stage 2 in all channels 
(wrong recording time). Most of these signal losses happened 
when the dentist, unfamiliar with used PSG equipment had set 
up the device to stop recording earlier than a subject woke up, 
but it also happened twice for an experienced technician in 
KUH. This clearly shows the need for recording devices with 
simple setups if unattended home PSG studies are to be 
conducted in smaller medical facilities, where the medical 
personnel is not familiar with the devices. In addition, subjects 
from UEF and KUH presumably were highly educated (often 
in health sciences), whereas subjects from the dental clinic had 
presumably varying educational background. These factors 
may have a significant role to play on the success rate of AES 
appliance, since the only failed recording caused by 
misapplied AES and the majority (76.3 %) of all signal data 
losses in stage 2 recordings occurred in recordings made in 
dental clinic. 
The measured electrical impedances in home environment 
are generally in line with and mostly lower compared to those 
TABLE VI 
PERCEPTION OF EASINESS TO APPLY THE EQUIPMENT 
Ease of applying the electrode set and 
other devices (1=easy, 10 =difficult) 
Stage 1 Stage 2 
p 
value 
EEG, EOG and mass-EMG electrodes 3.9 ± 2.4 3.3 ± 2.0 0.44¹ 
Sub-EMG electrodes* - 2.1 ± 1.4 - 
ECG electrodes* - 2.0 ± 1.9 - 
Other sensors 1.8 ± 1.0 2.0 ± 1.7 0.61¹ 
Cables 1.7 ± 0.9 1.9 ± 1.2 0.96¹ 
  The perceived ease of applying the first (Stage 1, n = 19) and second (Stage 
2, n = 21) designs of newly designed ambulatory electrode sets and other 
polysomnography (PSG) sensors (mean ± SD).  
  ¹ = Mann-Whitney U-test, * = Included only in the questionnaires in 
recordings made in stage 2.  EEG = electroenchephalography, EOG = 
electroocuclography, mass-EMG = masseter electromyography, sub-EMG = 
submental electromyography. 
 
Fig. 3. Two 20-second samples of recorded signals with ambulatory 
electrode set (AES) in home setting. AES enables recording of submental 
electromyography (sub-EMG, channels S1-SF and S2-SF), 
electroencephalography (channels Af7-T10, Fp1-T10, Fp2-T9 and Af8-T9), 
electrooculography (channels F7-T10 and F8-T9), bipolar masseter 
electromyography (mass-EMG, channels MassL and MassR) and 
electrocardiography (ECG). Nocturnal activity and audio were also recorded. 
Distinction between (a) phasic (with 6 bursts) and (b) tonic rhythmic 
masticatory muscle (RMMA) activity could easily be made based on the 
clear signals on MassL and MassR channels. RMMA events were 
distinguished from other orofacial or muscular activity and awake bruxism 
with the help of audio channel and sleep staging according to the flowchart 
in Fig. 2. An arousal event precedes RMMA events in (a) and (b), in addition 
to a clear increase of heart rate (HR) in (b), something which could be 
utilized for automatic recognition of RMMA events. 
 
 8 
reported in our earlier study in lab environment [10]: (44.6 ± 
8.0) kΩ at 30 Hz and (53.1 ± 8.6) kΩ at 15 Hz on skin 
prepared only by wiping with an ethanol soaked cotton pad. 
Electrical impedances in this range have a negligible impact 
on signal quality when modern amplifiers with high input 
impedances are used [37]. This shows that the electrode 
contacts and skin impedances are most of the time adequate 
even when subjects self-apply the electrodes and perform a 
skin preparation in a simple manner by themselves. 
This study had limitations in the small study population and 
in the lack of comparative concomitant PSG recordings with 
standardly postitioned electrodes. However, in this study we 
were especially interested in the success rate and technical 
quality of PSG recordings where subjects applied the 
electrodes by themselves. Since standard cup electrodes would 
have needed to be applied by a technician anyway, we thought 
that it would have interfered with the testing of self-
applicability. Furthermore, we felt that making comparative 
non-concomitant recordings was not necessary, as the 
approximate comparison of technical quality of AES could be 
made to type 2 PSG technical quality studies made by others 
[30]–[34]. The results of this study could not be generalized to 
all sleep disorders and patient groups and the technical quality 
of AES in the diagnostics of other sleep disorders with 
differing equipment should be investigated separately.  
To conclude, in order to fully utilize the potential of the self-
applicable AES in home PSG, further research is needed on 
the following topics: 
1) Development of different sized or stretchable electrodes. 
2) Development of even more reliably attaching electrodes 
that are easier to apply to reduce the number of channels 
needed. 
3) Implementation of wireless data transfer. 
4) Development of simpler devices and softwares to ensure 
the high technical quality of the recordings in varying 
user environments. 
5) Confirming the diagnostic accuracy of AES for SB in a 
large validation study in comparison to sleep lab PSG. 
6) Development of easily applicable occipital electrodes that 
would produce good quality signals even on hairy areas, 
enabling more accurate N1 sleep stage scoring. 
7) Development of automatic RMMA detection techniques. 
V. CONCLUSIONS 
AES showed good reliability in unattended home PSG as 
well as easy and secure self-applicability by subjects. This 
study demonstrated the benefits of multi-channel 
measurements in unattended home PSG, when subjects apply 
the equipment themselves. Proportion of recordings with high 
quality data from EEG channels of AES were found to be 
comparable to that of conventional home PSG. In the future, 
easily applicable AES may offer more accuracy and 
availability to diagnostics of SB and other sleep disorders such 
as sleep apnea that requires home PSG but are often currently 
lacking EEG for sleep staging. If automatic analysis methods 
are implemented, it should be done in accordance to the fact 
that single channels of AES may have high proportions of 
signal quality problems. 
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